Search

Keli L. Hill

Examiner (ID: 14362, Phone: (571)272-4375 , Office: P/2912 )

Most Active Art Unit
2912
Art Unit(s)
2912, 2922, 2952
Total Applications
3649
Issued Applications
3514
Pending Applications
12
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5474291 [patent_doc_number] => 20090247457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'NEUROTROPHIC COMPONENTS OF THE ADNF I COMPLEX' [patent_app_type] => utility [patent_app_number] => 12/197915 [patent_app_country] => US [patent_app_date] => 2008-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 26874 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247457.pdf [firstpage_image] =>[orig_patent_app_number] => 12197915 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/197915
NEUROTROPHIC COMPONENTS OF THE ADNF I COMPLEX Aug 24, 2008 Abandoned
Array ( [id] => 5264358 [patent_doc_number] => 20090117043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Antibodies That Specifically Bind to Neurokinin B' [patent_app_type] => utility [patent_app_number] => 12/191875 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51026 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117043.pdf [firstpage_image] =>[orig_patent_app_number] => 12191875 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/191875
Antibodies That Specifically Bind to Neurokinin B Aug 13, 2008 Abandoned
Array ( [id] => 4618766 [patent_doc_number] => 07998480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Human BNP immunospecific antibodies' [patent_app_type] => utility [patent_app_number] => 12/189232 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 30406 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998480.pdf [firstpage_image] =>[orig_patent_app_number] => 12189232 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/189232
Human BNP immunospecific antibodies Aug 10, 2008 Issued
Array ( [id] => 6443891 [patent_doc_number] => 20100144616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Neuroprotective methods and reagents' [patent_app_type] => utility [patent_app_number] => 12/220865 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26127 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144616.pdf [firstpage_image] =>[orig_patent_app_number] => 12220865 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/220865
Neuroprotective methods and reagents Jul 27, 2008 Abandoned
Array ( [id] => 6422803 [patent_doc_number] => 20100167937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Multiple forms of Alzheimer\'s disease based on differences in concentrations of protein biomarkers in blood serum' [patent_app_type] => utility [patent_app_number] => 12/217885 [patent_app_country] => US [patent_app_date] => 2008-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 33886 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167937.pdf [firstpage_image] =>[orig_patent_app_number] => 12217885 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/217885
Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum Jul 7, 2008 Abandoned
Array ( [id] => 210538 [patent_doc_number] => 07625864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Methods and compositions for treating ocular disorders' [patent_app_type] => utility [patent_app_number] => 12/164938 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3904 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/625/07625864.pdf [firstpage_image] =>[orig_patent_app_number] => 12164938 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/164938
Methods and compositions for treating ocular disorders Jun 29, 2008 Issued
Array ( [id] => 6395449 [patent_doc_number] => 20100178293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/665401 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2233 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20100178293.pdf [firstpage_image] =>[orig_patent_app_number] => 12665401 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/665401
USE OF ANTIBODIES AGAINST THE CD52 ANTIGEN FOR THE TREATMENT OF NEUROLOGICAL DISORDERS, PARTICULARLY TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY AND ALZHEIMER'S DISEASE Jun 9, 2008 Abandoned
Array ( [id] => 4628909 [patent_doc_number] => 08007791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Prevention and treatment of complement-associated eye conditions' [patent_app_type] => utility [patent_app_number] => 12/154466 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18554 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/007/08007791.pdf [firstpage_image] =>[orig_patent_app_number] => 12154466 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/154466
Prevention and treatment of complement-associated eye conditions May 21, 2008 Issued
Array ( [id] => 6420254 [patent_doc_number] => 20100150924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'REGULATION OF MYELINATION BY NECTIN-LIKE (NECL) MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/600833 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 28083 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150924.pdf [firstpage_image] =>[orig_patent_app_number] => 12600833 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/600833
REGULATION OF MYELINATION BY NECTIN-LIKE (NECL) MOLECULES May 21, 2008 Abandoned
Array ( [id] => 111881 [patent_doc_number] => 07718605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Compounds for intracellular delivery of therapeutic moieties to nerve cells' [patent_app_type] => utility [patent_app_number] => 12/116886 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6127 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718605.pdf [firstpage_image] =>[orig_patent_app_number] => 12116886 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/116886
Compounds for intracellular delivery of therapeutic moieties to nerve cells May 6, 2008 Issued
Array ( [id] => 6245635 [patent_doc_number] => 20100136002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'METHODS FOR TREATING AND PREVENTING MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/598525 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16472 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136002.pdf [firstpage_image] =>[orig_patent_app_number] => 12598525 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/598525
Methods for treating and preventing multiple sclerosis Apr 30, 2008 Issued
Array ( [id] => 4675639 [patent_doc_number] => 20080213268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'NEUROPILIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/107544 [patent_app_country] => US [patent_app_date] => 2008-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32654 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213268.pdf [firstpage_image] =>[orig_patent_app_number] => 12107544 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/107544
Neuropilin antagonists Apr 21, 2008 Issued
Array ( [id] => 6265011 [patent_doc_number] => 20100297678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'BIOMARKERS FOR MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/595597 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10537 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297678.pdf [firstpage_image] =>[orig_patent_app_number] => 12595597 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/595597
Biomarkers for multiple sclerosis Apr 13, 2008 Issued
Array ( [id] => 4719338 [patent_doc_number] => 20080241860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'METHODS AND APPARATUS TO RECOGNIZE NERVE INJURIES' [patent_app_type] => utility [patent_app_number] => 12/101662 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4732 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241860.pdf [firstpage_image] =>[orig_patent_app_number] => 12101662 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/101662
METHODS AND APPARATUS TO RECOGNIZE NERVE INJURIES Apr 10, 2008 Abandoned
Array ( [id] => 6423802 [patent_doc_number] => 20100168016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/593988 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36628 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168016.pdf [firstpage_image] =>[orig_patent_app_number] => 12593988 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/593988
DIAGNOSIS AND TREATMENT OF DISEASES CAUSED BY MISFOLDED PROTEINS Apr 10, 2008 Abandoned
Array ( [id] => 4845475 [patent_doc_number] => 20080181883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Purified Antigen for Alzheimer\'s Disease and Methods of Obtaining and Using Same' [patent_app_type] => utility [patent_app_number] => 12/060350 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14402 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181883.pdf [firstpage_image] =>[orig_patent_app_number] => 12060350 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/060350
Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same Mar 31, 2008 Abandoned
Array ( [id] => 4720067 [patent_doc_number] => 20080242590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'New Method 706' [patent_app_type] => utility [patent_app_number] => 12/057464 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21455 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242590.pdf [firstpage_image] =>[orig_patent_app_number] => 12057464 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/057464
New Method 706 Mar 27, 2008 Abandoned
Array ( [id] => 4710669 [patent_doc_number] => 20080299195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/054334 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5970 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299195.pdf [firstpage_image] =>[orig_patent_app_number] => 12054334 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/054334
USE OF RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE Mar 23, 2008 Abandoned
Array ( [id] => 4740543 [patent_doc_number] => 20080234196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Treatment and prevention of vascular dementia' [patent_app_type] => utility [patent_app_number] => 12/072914 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21421 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234196.pdf [firstpage_image] =>[orig_patent_app_number] => 12072914 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/072914
Treatment and prevention of vascular dementia Feb 27, 2008 Issued
Array ( [id] => 4728530 [patent_doc_number] => 20080208074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Methods and Systems for Characterizing and Generating a Patient-Specific Seizure Advisory System' [patent_app_type] => utility [patent_app_number] => 12/035335 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20390 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20080208074.pdf [firstpage_image] =>[orig_patent_app_number] => 12035335 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/035335
Methods and Systems for Characterizing and Generating a Patient-Specific Seizure Advisory System Feb 20, 2008 Abandoned
Menu